Alzamend Neuro, Inc.
Open: 3:11 PM
ALZN Stock Price Graph
ALZN Stock Price Today
Alzamend Neuro, Inc. (ALZN) stock rallied over 9.35% intraday to trade at $1.17 a share on NASDAQ. The stock opened with a loss of -82.00% at $0.19 and touched an intraday high of $0.20, rising 9.35% against the last close of $1.07. The Alzamend Neuro, Inc. in stock market went to a low of $0.17 during the session.
ALZN Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
ALZN Stock Price History Chart
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and AL002 that completed preclinical stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Frequently Asked Questions
What is the current Alzamend Neuro, Inc. (ALZN) stock price?
Alzamend Neuro, Inc. (NASDAQ: ALZN) stock price is $1.17 in the last trading session. During the trading session, ALZN stock reached the peak price of $0.20 while $0.17 was the lowest point it dropped to. The percentage change in ALZN stock occurred in the recent session was 9.35% while the dollar amount for the price change in ALZN stock was $0.10.
ALZN's industry and sector of operation?
The NASDAQ listed ALZN is part of Biotechnology industry that operates in the broader Healthcare sector. Alzamend Neuro, Inc. , an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
Who are the executives of ALZN?
Mr. Henry C. W. Nisser Esq.
Executive Vice President, Gen. Counsel & Director
Mr. Stephan Jackman
Chief Executive Officer & Director
Mr. Kenneth S. Cragun CPA
Senior Vice President of Fin.
Mr. Henry C. W. Nisser Esq.
Exec. VP, Gen. Counsel & Director
How ALZN did perform over past 52-week?
ALZN's closing price is 0.63% higher than its 52-week low of $0.1715 where as its distance from 52-week high of $1.32 is -0.66%.
How many employees does ALZN have?
Number of ALZN employees currently stands at N/A. ALZN operates from 3500 Lenox Road NE, Atlanta, GA 30326, US.
Link for ALZN official website?
Official Website of ALZN is: https://www.alzamend.com
How do I contact ALZN?
How many shares of ALZN are traded daily?
ALZN stock volume for the day was 47909.00 shares. The average number of ALZN shares traded daily for last 3 months was 106.55 Thousands.
What is the market cap of ALZN currently?
The market value of ALZN currently stands at $7.57 Million with its latest stock price at $1.17 and N/A of its shares outstanding.